Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|July 12, 2022
Dysregulation of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis Revealed by Unbiased Profiling of Serum MetabolitesAnanta Paine, Paul S Brookes, Soumyaroop Bhattacharya, et al.JCI Insight|September 6, 2022
Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in sclerodermaRoberta G Marangoni, Poulami Datta, Ananta Paine, et al.Journal of Comparative Effectiveness Research|September 20, 2018
Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysisIain B McInnes, Peter Nash, Christopher Ritchlin, et al.The Journal of Investigative Dermatology|October 11, 2024
Imaging Mass Cytometry in Psoriatic Disease Reveals Immune Profile Heterogeneity in Skin and Synovial TissueLihi Eder, Stephan M Caucheteux, Somaieh Afiuni-Zadeh, et al.Annals of the Rheumatic Diseases|April 22, 2016
Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)Arthur Kavanaugh, Lluis Puig, Alice B Gottlieb, et al.Current Rheumatology Reports|September 22, 2020
Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMANStacie Bell, Joseph F Merola, Dan E Webster, et al.Annals of the Rheumatic Diseases|November 8, 2025
CD3+ immune cell endotypes are associated with PsA disease phenotype and response to advanced therapy: an integrated mass cytometry and proteomics cohort studyLihi Eder, Steven Dang, Stephane M Caucheteux, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2024
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical ResponsesOliver FitzGerald, Dafna D Gladman, Philip J Mease, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 9, 2023
Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards PreventionLihi Eder, Ker-Ai Lee, Vinod Chandran, et al.Arthritis Care & Research|August 3, 2016
Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic ArthritisProton Rahman, Lluis Puig, Alice B Gottlieb, et al.Pageof 7